Apnimed
Clinical trials sponsored by Apnimed, explained in plain language.
-
Sleep apnea pill shows promise in phase 3 trial
Symptom relief CompletedThis study tested a combination pill called AD109 against a placebo in 646 adults with obstructive sleep apnea who cannot tolerate CPAP machines. The goal was to see if the pill reduces breathing pauses during sleep. Participants took the medication or placebo for 6 months, and r…
Phase: PHASE3 • Sponsor: Apnimed • Aim: Symptom relief
Last updated May 17, 2026 12:45 UTC
-
New pill could ease sleep apnea without the mask
Symptom relief CompletedThis study tested a combination pill called AD109 (aroxybutynin and atomoxetine) against a placebo in 660 adults with obstructive sleep apnea who cannot or will not use a CPAP machine. The goal was to see if the pill reduces breathing pauses during sleep and improves fatigue. Par…
Phase: PHASE3 • Sponsor: Apnimed • Aim: Symptom relief
Last updated May 15, 2026 11:57 UTC